Jean Pierre Pignon
Overview
Explore the profile of Jean Pierre Pignon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
833
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fayard F, Petit C, Lacas B, Pignon J
BMJ Open
. 2018 Aug;
8(8):e020499.
PMID: 30104312
Objective: To compare the characteristics, quality and treatment effects of randomised clinical trials (RCTs) by individual patient data (IPD) availability, in trials eligible for 18 IPD meta-analyses (MA). Design: Trial...
2.
Mezquita L, Charrier M, Faivre L, Dupraz L, Lueza B, Remon J, et al.
Lung Cancer
. 2017 Dec;
112:10-15.
PMID: 29191581
Introduction: The class I human leucocyte antigen (HLA) molecules play a critical role as an escape mechanism of antitumoral immunity. HLA-A2 status has been evaluated as a prognostic factor in...
3.
Ribassin-Majed L, Marguet S, Lee A, Ng W, Ma J, Chan A, et al.
J Clin Oncol
. 2016 Dec;
35(5):498-505.
PMID: 27918720
Purpose The role of adjuvant chemotherapy (AC) or induction chemotherapy (IC) in the treatment of locally advanced nasopharyngeal carcinoma is controversial. The individual patient data from the Meta-Analysis of Chemotherapy...
4.
Burdett S, Rydzewska L, Tierney J, Fisher D, Parmar M, Arriagada R, et al.
Cochrane Database Syst Rev
. 2016 Oct;
10:CD002142.
PMID: 27727451
Background: The role of postoperative radiotherapy (PORT) in the treatment of patients with completely resected non-small cell lung cancer (NSCLC) was not clear. A systematic review and individual participant data...
5.
Burdett S, Rydzewska L, Tierney J, Fisher D, Parmar M, Arriagada R, et al.
Cochrane Database Syst Rev
. 2016 Sep;
9:CD002142.
PMID: 27684386
Background: The role of postoperative radiotherapy (PORT) in the treatment of patients with completely resected non-small cell lung cancer (NSCLC) was not clear. A systematic review and individual participant data...
6.
Blanchard P, Ribassin-Majed L, Lee A, Pignon J
Eur J Cancer
. 2016 Jan;
56:183-185.
PMID: 26755270
No abstract available.
7.
Blanchard P, Lee A, Marguet S, Leclercq J, Ng W, Ma J, et al.
Lancet Oncol
. 2015 May;
16(6):645-55.
PMID: 25957714
Background: A previous individual patient data meta-analysis by the Meta-Analysis of Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group to assess the addition of chemotherapy to radiotherapy showed that it improves...
8.
Burdett S, Pignon J, Tierney J, Tribodet H, Stewart L, Le Pechoux C, et al.
Cochrane Database Syst Rev
. 2015 Mar;
(3):CD011430.
PMID: 25730344
Background: To evaluate the effects of administering chemotherapy following surgery, or following surgery plus radiotherapy (known as adjuvant chemotherapy) in patients with early stage non-small cell lung cancer (NSCLC),we performed...
9.
Abedallaa N, Tremblay L, Baey C, Fabre D, Planchard D, Pignon J, et al.
J Thorac Oncol
. 2012 May;
7(7):1179-83.
PMID: 22617247
Introduction: Surgical resection of an undiagnosed lung lesion may lead to unintentional removal of small-cell lung cancer (SCLC). The benefit of perioperative chemotherapy in resected SCLC or large-cell neuroendocrine carcinomas...
10.
Delbaldo C, Michiels S, Rolland E, Syz N, Soria J, Le Chevalier T, et al.
Cochrane Database Syst Rev
. 2012 Apr;
(4):CD004569.
PMID: 22513924
Background: Randomized trials have demonstrated that adding a drug to a single-agent or to a two-agent regimen increased the tumor response rate in patients with advanced non-small cell lung cancer...